Clinical Trials · NCT04060992

Hormonal Effects of the Oral Gonadotropin Releasing Hormone (GnRH) Antagonist at Different Periods of the Menstrual Cycle

UnknownPhase 4Gonadorelin (Unclear)
Phase
Phase 4
Recruitment status
Unknown
Sponsor
University of Southern California
Enrollment
12
Start date
Oct 2019
Locations
See registry
Primary endpoint
Suppression of gonadotropin and pituitary hormones as measured by hormonal assay status post short-term administration of elagolix
View Gonadorelin compound reference